Moneycontrol PRO
you are here: HomeNewsLaurus labs
laurus labs
Jump to
125 Results Found
  • Moneycontrol Pro Panorama | The volatility signs are flashing red Jan 06, 2022 03:53 PM IST

    Moneycontrol Pro Panorama | The volatility signs are flashing red

    In today’s edition of Moneycontrol Pro Panorama: The fear gauge is sending a warning to investors, government spending capacity, Sona BLW, Laurus Labs, tyre companies' capex, crypto trading, and more

  • Laurus Labs: Pick-up in fermentation opportunity a key watch Jan 06, 2022 12:04 PM IST

    Laurus Labs: Pick-up in fermentation opportunity a key watch

    As per a recent presentation by chief business officer, Laurus Bio, Rajesh Krishnamurthy, for most of the cultivated meat manufacturers, about two-thirds of the variable cost is triggered by proteins and protein growth factors. And Laurus plans to reduce its cost through economies of scale and process innovation.

  • Buy Laurus Labs: target of Rs 735: Sharekhan Jan 03, 2022 11:57 AM IST

    Buy Laurus Labs: target of Rs 735: Sharekhan

    Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 735 in its research report dated December 31, 2021.

  • Trade Spotlight | What should you do with ONGC, Laurus Labs, Adani Ports, Zee stocks? Nov 25, 2021 07:07 AM IST

    Trade Spotlight | What should you do with ONGC, Laurus Labs, Adani Ports, Zee stocks?

    Here's what Gaurav Sharma of Globe Capital Markets, recommends investors should do with these stocks when the market resumes trading today.

  • Buy Laurus Labs; target of Rs 690: Motilal Oswal Nov 22, 2021 03:04 PM IST

    Buy Laurus Labs; target of Rs 690: Motilal Oswal

    Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 690 in its research report dated November 21, 2021.

  • Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore Nov 20, 2021 11:31 AM IST

    Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore

    Additionally, Laurus Labs' senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filing

  • Laurus Labs: New growth levers taking shape Nov 02, 2021 10:02 AM IST

    Laurus Labs: New growth levers taking shape

    The businesses to track for Laurus Labs, as far as future growth trajectory is concerned, are that of synthesis and biotech

  • Laurus Labs Consolidated September 2021 Net Sales at Rs 1,203.48 crore, up 5.68% Y-o-Y Oct 29, 2021 02:22 PM IST

    Laurus Labs Consolidated September 2021 Net Sales at Rs 1,203.48 crore, up 5.68% Y-o-Y

  • Laurus Labs Consolidated September 2021 Net Sales at Rs 1,203.48 crore, up 5.68% Y-o-Y Oct 28, 2021 11:11 PM IST

    Laurus Labs Consolidated September 2021 Net Sales at Rs 1,203.48 crore, up 5.68% Y-o-Y

  • Laurus Labs Standalone September 2021 Net Sales at Rs 1,176.20 crore, up 4.34% Y-o-Y Oct 28, 2021 11:00 PM IST

    Laurus Labs Standalone September 2021 Net Sales at Rs 1,176.20 crore, up 4.34% Y-o-Y

  • Buy Laurus Labs: target of Rs 800: Sharekhan Sep 29, 2021 02:22 PM IST

    Buy Laurus Labs: target of Rs 800: Sharekhan

    Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated September 28, 2021.

  • Buy Laurus Labs: target of Rs 800: Sharekhan Aug 02, 2021 02:10 PM IST

    Buy Laurus Labs: target of Rs 800: Sharekhan

    Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated July 30, 2021.

  • Laurus Labs Standalone June 2021 Net Sales at Rs 1,220.60 crore, up 25.78% Y-o-Y Jul 29, 2021 10:44 PM IST

    Laurus Labs Standalone June 2021 Net Sales at Rs 1,220.60 crore, up 25.78% Y-o-Y

  • Laurus Labs Consolidated June 2021 Net Sales at Rs 1,278.50 crore, up 31.22% Y-o-Y Jul 29, 2021 10:44 PM IST

    Laurus Labs Consolidated June 2021 Net Sales at Rs 1,278.50 crore, up 31.22% Y-o-Y

  • Buy Laurus Labs; target of Rs 800: Motilal Oswal Jul 07, 2021 03:41 PM IST

    Buy Laurus Labs; target of Rs 800: Motilal Oswal

    Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 800 in its research report dated July 06, 2021.

  • Laurus Labs receives licence from DRDO to manufacture and market COVID drug 2DG Jul 02, 2021 03:23 PM IST

    Laurus Labs receives licence from DRDO to manufacture and market COVID drug 2DG

    2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.

  • Buy Laurus Labs: target of Rs 750: Sharekhan Jul 02, 2021 01:29 PM IST

    Buy Laurus Labs: target of Rs 750: Sharekhan

    Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 750 in its research report dated July 01, 2021.

  • Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity Jun 01, 2021 11:36 AM IST

    Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity

    The most positive development for the last fiscal year has been a sharp reduction in leverage which positions Aurobindo Pharma for capex commitments in the API, vaccine and biosimilars space

  • Buy Laurus Labs; target of Rs 550: ICICI Direct May 25, 2021 05:07 PM IST

    Buy Laurus Labs; target of Rs 550: ICICI Direct

    ICICI Direct is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 550 in its research report dated April 30, 2021.

  • Laurus Labs’ $1 billion sales target needs a bit of luck on execution May 04, 2021 09:30 AM IST

    Laurus Labs’ $1 billion sales target needs a bit of luck on execution

    Laurus Labs is already halfway past its $1 billion revenue target and has new capacities and products to back up its growth plan

  • Laurus Labs: Diversification to speed up in FY23; add on declines May 03, 2021 11:06 AM IST

    Laurus Labs: Diversification to speed up in FY23; add on declines

    There is a perceptible change in the Laurus Labs' management commentary in the last 18 months that points to growth sustenance for the medium term

  • Laurus Labs Consolidated March 2021 Net Sales at Rs 1,411.93 crore, up 68.26% Y-o-Y Apr 29, 2021 07:30 PM IST

    Laurus Labs Consolidated March 2021 Net Sales at Rs 1,411.93 crore, up 68.26% Y-o-Y

  • Laurus Labs Standalone March 2021 Net Sales at Rs 1,398.74 crore, up 68.68% Y-o-Y Apr 29, 2021 07:13 PM IST

    Laurus Labs Standalone March 2021 Net Sales at Rs 1,398.74 crore, up 68.68% Y-o-Y

  • Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan

    Net Sales are expected to increase by 56.6 percent Y-o-Y (up 2 percent Q-o-Q) to Rs. 1,314.3 crore, according to Sharekhan.

  • Buy Laurus Labs: target of Rs 450: Sharekhan Mar 12, 2021 08:57 AM IST

    Buy Laurus Labs: target of Rs 450: Sharekhan

    Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 450 in its research report dated March 10, 2021.

Sections
ISO 27001 - BSI Assurance Mark